Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Gabapentin × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 9 Breast 5 Other 3 Genitourinary 3 Lymphoid 2 Thoracic 1 Other hematologic neoplasm 1 Gastrointestinal 1 Dermatologic 1 CNS 1

Conditions

Glioblastoma 1 Epilepsy 1

Interventions

Temozolomide 557 Radiotherapy 370 Bevacizumab 229 Magnetic Resonance Spectroscopy 201 Cyclophosphamide 156 Radiosurgery 150 Carboplatin 139 Radiation 114 Etoposide 113 Irinotecan 104 Vincristine 96 Cisplatin 86 Filgrastim 83 Specimen Handling 80 pembrolizumab 79 Nivolumab 75 Lomustine 75 Surgical Procedures, Operative 71 Topotecan 62 Melphalan 52 sargramostim 51 Carmustine 51 Radiotherapy, Intensity-Modulated 50 Isotretinoin 48 Granulocyte Colony-Stimulating Factor 47 Doxorubicin 46 Peripheral Blood Stem Cell Transplantation 45 Chemotherapy, Adjuvant 45 Erlotinib Hydrochloride 44 Blood Specimen Collection 44

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05664464 2024-05-10

GLUGLIO

University of Zurich

Phase 1/2 Recruiting

Epilepsy, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡